Crestwell Healthcare Limited
PSX DPS snapshot · 16/11/2026, 18:10:00 PKT
CWHC chart
PSX source prices; historical corporate-action adjustments are not verified. 16/10/2026 – 16/11/2026
Fundamentals snapshot
- Annual EPS · FY 2026
- Rs -0.46
- Quarter EPS · Q1 2027
- Rs -0.17
- P/E (TTM)
- —
- Annual dividend yield
- —
- Book value / share · 2026 Q3 · Basis not specified
- Rs -0.02
- Market cap
- Rs 1.48B
Trading Statistics
Earnings & valuation
PSX · unconsolidated results ↗- Annual EPS
- -0.46
- Latest quarter EPS
- -0.17
- P/E · TTM
- —
- P/E · annual EPS
- —
- Revenue growth · YoY
- —
- Annual dividend yield
- —
FY 2026
Q1 2027
PSX · unconsolidated TTM
FY 2026
FY 2026
Annual payout unavailable
Valuation, returns & financial health
Source: SCSTrade ↗Basis not specified · Source snapshot price: Rs 20.77
Annual dividends
- Annual dividend per share
- —
Period not supplied
Book value & valuation
- Book value per share
- Rs -0.02
- Price-to-book · PSX price
- —
- Enterprise value · source reported
- 1.48B PKR
- EV / EBITDA · source reported
- —
2026 Q3
2026 Q3
2026 Q1
Period not supplied
Profitability & returns
- Gross profit margin
- —
- Operating profit margin
- —
- Net profit margin
- —
- EBITDA margin
- —
- Return on equity (ROE)
- —
- Return on assets (ROA)
- —
- Return on capital employed (ROCE)
- —
Period not supplied
Period not supplied
Period not supplied
Period not supplied
Period not supplied
Period not supplied
Period not supplied
Financial health
- Current ratio
- 0.30x
- Quick ratio
- —
- Inventory turnover
- —
- Asset turnover
- —
- Equity-to-assets
- —
2026 Q3
Period not supplied
Period not supplied
Period not supplied
Period not supplied
Statement amounts in PKR thousands; EPS in PKR per share.
Annual results
| Metric | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Sales | — | 6,145 | 17,302 | 3,348 |
| Profit after Taxation | -8,208 | -8,405 | 1,668 | -2,904 |
| EPS | -0.46 | -0.47 | 0.09 | -0.16 |
Quarterly results
| Metric | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Sales | — | — | — | — |
| Profit after Taxation | -10,095 | -493 | -1,124 | -266 |
| EPS | -0.17 | -0.03 | -0.06 | -0.01 |
Historical margins & growth · PSX reported
| Metric | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Profit Margin (%) | — | -29.07 | 13.47 | -81.43 |
| Net Profit Margin (%) | — | -136.77 | 9.64 | -86.75 |
| EPS Growth (%) | 2.13 | -600.00 | 157.67 | -352.78 |
| PEG | -81.88 | 0.03 | 0.81 | 0.10 |
Dividend & payout history
PSX payouts ↗No payout rows returned by PSX for this company.
Source reports & disclosures
Daily technicals
Based on PSX close · 16/11/2026
- RSI (14) · Wilder
- 41.42
- MACD (12, 26)
- -1.27
- MACD signal (9)
- -1.71
- MACD histogram
- 0.43
- 20-session average volume
- 4,186,889
- Relative volume (20)
- 0.33x
Neutral zone
Daily closing prices
EMA of MACD
Moving averages
| Average | Value (PKR) | Last close |
|---|---|---|
| SMA 20 | 21.64 | Below |
| SMA 50 | 24.73 | Below |
| SMA 200 | 41.34 | Below |
| EMA 20 | 21.90 | Below |
| EMA 50 | 27.70 | Below |
- 52-week closing low
- Rs 12.63
- 52-week closing high
- Rs 120.48
- Last daily close
- Rs 20.77
Calculated from available daily PSX history. Price indicators, not trading recommendations.
Competitors
PHARMACEUTICALS · same-sector companies| Company | Price (PKR) | Session % | P/E (TTM) | PSX yield · period unspecified | Market cap | 1-year price % |
|---|---|---|---|---|---|---|
| CWHCCrestwell Healthcare Limited | 20.77 | -2.31% | — | 0% | Rs 1.48B | 61.01% |
| GLAXOGlaxoSmithKline Pakistan Limited | 339.59 | 0.96% | 9.85x | 6.07% | Rs 108.15B | -13.75% |
| ABOTAbbott Laboratories (Pakistan) Limited | 1,003.93 | 0.39% | 10.59x | 4.36% | Rs 98.29B | -7.97% |
| HALEONHaleon Pakistan Limited | 689.69 | -1.06% | 12.39x | 3.61% | Rs 80.73B | -16.83% |
| HINOONHighnoon Laboratories Limited | 956.76 | -0.3% | 12.33x | 5.36% | Rs 50.69B | -14.37% |
| SEARLThe Searle Company Limited | 79.43 | 0.27% | 12.02x | 0% | Rs 46.72B | -23.15% |
| AGPAGP Limited | 155.45 | -0.59% | 24.33x | 5.12% | Rs 43.53B | -17.24% |
| HPLHoechst Pakistan Limited | 3,996.58 | 0.14% | 11.03x | 6.86% | Rs 38.55B | -4.65% |
| FEROZFerozsons Laboratories Limited | 364.92 | 0.67% | 23.07x | 1.57% | Rs 15.86B | -8.99% |
| CPHLCiti Pharma Ltd. | 63.54 | 0.19% | 17.85x | 0% | Rs 14.52B | -23.74% |
| GSKCHGlaxoSmithKline Consumer Healthcare | 120.23 | -3.13% | — | 0% | Rs 14.07B | 0% |
Company news
No company-specific headlines matched in the current 14-day feed.
Company Announcements
PSX company filings and original source documents
SHARIAH COMPLIANCE CERTIFICATE OF CRESTWELL HEALTHCARE LIMITED
Transmission of Quarterly Report for the Period Ended 30-Sep-2026.
Financial Results for the Quarter Ended 30-Sep-2026.
Extracts of Resolutions passed by the members of Crestwell Healthcare Limited in respect of 33rd AGM held on 28-Oct-2026.
About Crestwell Healthcare Limited
PHARMACEUTICALSCrestwell Healthcare Limited, formerly S. G. Power Limited ("the Company") was incorporated in Pakistan as a public limited company on February 10, 1994, under the (repealed) Companies Ordinance, 1984 (now Companies Act, 2017), and its shares are listed on the Pakistan Stock Exchange. The principal line of business of the Company from power generation to the manufacturing, marketing, and distribution of pharmaceutical products.
Leadership
- CEO
- Umer Ali Malik
- Chairperson
- Mian Ateeq Ur Rehman
- Company Secretary
- Usman A. Khan
Ownership & market structure
- Market cap (PKR)
- Rs 1.48B
- Total shares
- 71,332,867
- Free-float shares
- 67,766,224
- Free float
- 95.00%
Listed indices: ALLSHR,KMIALLSHR
KMI index membership reported by PSX.
Company contacts
- ADDRESS
- 2nd Floor, FNE House, 179 Abubakar Block, New Garden Town, Main Canal Road, Lahore.
- REGISTRAR
- M/s F.D Registrar Services (SMC-Pvt.) Limited, Office # 1705, 17th Floor, Saima Trade Tower 'A', I.I Chundrigar Road, Karachi
- AUDITOR
- M/s. Parker Russell-A.J.S, Chartered Accountants
- Fiscal Year End
- June
